{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:36:26Z","timestamp":1778852186351,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.jagp.2020.12.032","type":"journal-article","created":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T05:52:42Z","timestamp":1610430762000},"page":"899-913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series"],"prefix":"10.1016","volume":"29","author":[{"given":"Orly","family":"Lipsitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Di Vincenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle S.","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yena","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla M.","family":"Teopiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger C.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangguang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehala","family":"Subramaniapillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair J.","family":"Flint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Kratiuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2020.12.032_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jagp.2017.06.011","article-title":"Depression among older adults: a 20-year update on five common myths and misconceptions","volume":"26","author":"Haigh","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0002","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/JGP.0b013e3180437d9e","article-title":"Lifetime and 12-month prevalence of diagnostic and statistical manual of mental disorders, disorders among older African Americans: findings from the National Survey of American Life","volume":"15","author":"Ford","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0003","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1600-0447.2007.01017.x","article-title":"Prevalence and incidence of depressive disorder: the Baltimore ECA follow-up, 1981\u20132004","volume":"116","author":"Eaton","year":"2007","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.jagp.2020.12.032_bib0004","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/JGP.0b013e3181ad4f5a","article-title":"Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the National Comorbidity Survey-Replication The American","volume":"17","author":"Gum","year":"2009","journal-title":"J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S0924270800030829","article-title":"Prevalence of mental disorders in the elderly: the Australian National Mental Health and Well-being","volume":"18","author":"Trollor","year":"2006","journal-title":"Survey Acta Neuropsychiatrica"},{"key":"10.1016\/j.jagp.2020.12.032_bib0006","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jamda.2007.09.007","article-title":"Depression in long-term care","volume":"9","author":"Thakur","year":"2008","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jagp.2020.12.032_bib0007","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1017\/S1041610210000608","article-title":"Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review","volume":"22","author":"Seitz","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2020.12.032_bib0008","doi-asserted-by":"crossref","unstructured":"Alexopoulos GS: Mechanisms and treatment of late-life depression translational psychiatry 2019; 9. Available athttp:\/\/dx.doi.org\/10.1038\/s41398-019-0514-6.","DOI":"10.1038\/s41398-019-0514-6"},{"key":"10.1016\/j.jagp.2020.12.032_bib0009","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neubiorev.2016.07.003","article-title":"Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms","volume":"74","author":"Penninx","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.jagp.2020.12.032_bib0010","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1080\/13607863.2014.967174","article-title":"The relationship between depression and frailty syndrome: a systematic review","volume":"19","author":"Buigues","year":"2015","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jagp.2020.12.032_bib0011","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(05)66665-2","article-title":"Depression in the elderly","volume":"365","author":"Alexopoulos","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2020.12.032_bib0012","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0013","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1001\/archpsyc.59.7.605","article-title":"The natural history of late-life depression: a 6-year prospective study in the community","volume":"59","author":"Beekman","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0014","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1532-5415.1999.tb01584.x","article-title":"The importance of subsyndromal depression in older primary care patients: prevalence and associated functional disability","volume":"47","author":"Lyness","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2020.12.032_bib0015","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1176\/appi.ajp.162.9.1588","article-title":"Prognosis of depression in old age compared to middle age: a systematic review of comparative studies","volume":"162","author":"Mitchell","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0016","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/da.22772","article-title":"Predictors of recurrence in remitted late-life depression","volume":"35","author":"Deng","year":"2018","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jagp.2020.12.032_bib0017","first-page":"1277","article-title":"An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression American","volume":"160","author":"Schneider","year":"2003","journal-title":"J Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0018","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1532-5415.2004.52015.x","article-title":"Efficacy, safety, and tolerability of sertraline in patients with late-life depression and comorbid medical illness","volume":"52","author":"Sheikh","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jagp.2020.12.032_bib0019","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S1041610295001888","article-title":"A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression","volume":"7","author":"Tollefson","year":"1995","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2020.12.032_bib0020","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.4088\/JCP.v64n0912","article-title":"Efficacy of controlled-release paroxetine in the treatment of late-life depression","volume":"64","author":"Rapaport","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0021","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMcp1402180","article-title":"Depression in the elderly","volume":"371","author":"Taylor","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jagp.2020.12.032_bib0022","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/JGP.0b013e3181591c09","article-title":"Escitalopram in the acute treatment of depressed patients aged 60 years or older","volume":"16","author":"Bose","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0023","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","article-title":"Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial","volume":"164","author":"Raskin","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0024","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.JGP.0000194645.70869.3b","article-title":"A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression","volume":"14","author":"Schatzberg","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0025","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4088\/JCP.v64n0804","article-title":"Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents","volume":"64","author":"Oslin","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0026","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/gps.591","article-title":"Hyponatraemia in elderly psychiatric patients treated with selective serotonin reuptake inhibitors and venlafaxine: a retrospective controlled study in an inpatient unit","volume":"17","author":"Kirby","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0027","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2016.08.017","article-title":"Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: a meta-analysis of observational studies","volume":"118","author":"Laporte","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jagp.2020.12.032_bib0028","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/00019442-200108000-00015","article-title":"Methylphenidate augmentation of citalopram in elderly depressed patients","volume":"9","author":"Lavretsky","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0029","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/S0140-6736(15)00308-6","article-title":"Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Lenze","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jagp.2020.12.032_bib0030","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0031","first-page":"19","article-title":"The timing of antidepressant effects: a comparison of diverse","volume":"3","author":"Machado-Vieira","year":"2010","journal-title":"Pharmacol Somat Treat Pharm"},{"key":"10.1016\/j.jagp.2020.12.032_bib0032","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","article-title":"Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial","volume":"170","author":"Murrough","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0033","doi-asserted-by":"crossref","first-page":"18r12475","DOI":"10.4088\/JCP.18r12475","article-title":"Oral ketamine for depression: a systematic review","volume":"80","author":"Rosenblat","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0034","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopsych.2009.08.038","article-title":"Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression","volume":"67","author":"aan het Rot","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0035","first-page":"152","article-title":"The use of ketamine as an antidepressant: a systematic review and meta-analysis human psychopharmacology","volume":"30","author":"Coyle","year":"2015","journal-title":"Clin Exp"},{"key":"10.1016\/j.jagp.2020.12.032_bib0036","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.jagp.2017.06.007","article-title":"Pilot randomized controlled trial of titrated subcutaneous ketamine in older patients with treatment-resistant depression","volume":"25","author":"George","year":"2017","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0037","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jagp.2019.10.008","article-title":"Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression\u2014TRANSFORM-3","volume":"28","author":"Ochs-Ross","year":"2020","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0038","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jad.2020.05.088","article-title":"The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: Results from the Canadian Rapid Treatment Center of Excellence","volume":"274","author":"McIntyre","year":"2020","journal-title":"J Affect Disord"},{"issue":"Suppl 13","key":"10.1016\/j.jagp.2020.12.032_bib0039","first-page":"23","article-title":"When at first you don't succeed: sequential strategies for antidepressant nonresponders","volume":"58","author":"Thase","year":"1997","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0040","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","year":"2013"},{"key":"10.1016\/j.jagp.2020.12.032_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2020.1776699","article-title":"Safety and tolerability of IV ketamine in adults with major depressive or bipolar disorder: results from the Canadian rapid treatment center of excellence","volume":"19","author":"Rodrigues","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jagp.2020.12.032_bib0042","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0043","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/0004867416631828","article-title":"Ketamine augmentation for outpatients with treatment-resistant depression: preliminary evidence for two-step intravenous dose escalation","volume":"51","author":"Cusin","year":"2017","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0044","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the clinician-administered dissociative states scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.jagp.2020.12.032_bib0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization","volume":"80","author":"Singh","year":"2016","journal-title":"Placebo-Controlled Study Biol Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0046","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3390\/ijerph15040771","article-title":"Predictors of response to ketamine in treatment resistant major depressive disorder and bipolar disorder","volume":"15","author":"Rong","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jagp.2020.12.032_bib0047","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jagp.2020.12.032_bib0048","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s12630-017-0833-0","article-title":"How to construct regression models for observational studies (and how NOT to do it!)","volume":"64","author":"Thorpe","year":"2017","journal-title":"Canadian J Anesth\/J Canadien d'anesth\u00e9sie"},{"key":"10.1016\/j.jagp.2020.12.032_bib0049","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jagp.2016.04.015","article-title":"Impact of prior treatment on remission of late-life depression with venlafaxine and subsequent aripiprazole or placebo augmentation","volume":"24","author":"Hsu","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jad.2018.02.049","article-title":"Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression","volume":"232","author":"Niciu","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2020.12.032_bib0051","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jad.2017.09.023","article-title":"Acute psychoactive effects of intravenous ketamine during treatment of mood disorders: analysis of the clinician administered dissociative state scale","volume":"227","author":"van Schalkwyk","year":"2018","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2020.12.032_bib0052","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jagp.2020.12.032_bib0053","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.jagp.2019.01.093","article-title":"Efficacy and safety of esketamine nasal spray plus an oral antidepressant in elderly patients with treatment-resistant depression","volume":"27","author":"Ochs-Ross","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jagp.2020.12.032_bib0054","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: a meta-analysis","volume":"276","author":"McIntyre","year":"2020","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jagp.2020.12.032_bib0055","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1089\/jpm.2012.0617","article-title":"Daily oral ketamine for the treatment of depression and anxiety in patients receiving hospice care: a 28-day open-label proof-of-concept","volume":"16","author":"Irwin","year":"2013","journal-title":"Trial J Palliat Med"},{"key":"10.1016\/j.jagp.2020.12.032_bib0056","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/da.22063","article-title":"Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions","volume":"30","author":"McIntyre","year":"2013","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jagp.2020.12.032_bib0057","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/YCO.0000000000000221","article-title":"Cognition in major depressive disorder: a \u201csystemically important functional index\u201d (SIFI)","volume":"29","author":"McIntyre","year":"2016","journal-title":"Curr Opin Psychiatry"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748121000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T04:31:34Z","timestamp":1761021094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748121000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1064748121000026"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2020.12.032","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2020.12.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}